# OnCo record bioinvent-international (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/bioinvent-international/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "bioinvent-international" ;
  schema:name "BioInvent International"@en ;
  schema:alternateName "BioInvent International AB"@en ;
  schema:description "BioInvent International is a Sweden-based biotechnology company running 4 late-stage cancer trials of BI-1607, Ipilimumab (YervoyTM and BI-1910 in melanoma, uveal melanoma and non-small-cell lung cancer."@en ;
  schema:url <https://onco.cc/companies/bioinvent-international/>, <https://www.bioinvent.com> ;
  schema:dateModified "2026-09-11"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Bioinvent> ;
  owl:sameAs <http://www.wikidata.org/entity/Q64227952> ;
  schema:citation <https://www.bioinvent.com>, <https://clinicaltrials.gov/search?lead=BioInvent%20International%20AB> ;
  onco:tag "ctgov-sponsor" ;
  schema:addressCountry "SE" ;
  onco:cancers <https://onco.cc/cancers/melanoma/>, <https://onco.cc/cancers/uveal-melanoma/>, <https://onco.cc/cancers/nsclc/>, <https://onco.cc/cancers/hcc/>, <https://onco.cc/cancers/ovarian/>, <https://onco.cc/cancers/peripheral-t-cell-lymphoma/> ;
  onco:trials <https://onco.cc/trials/nct04752826/>, <https://onco.cc/trials/nct06784648/>, <https://onco.cc/trials/nct06205706/>, <https://onco.cc/trials/nct04219254/> .